Closing the long standing gaps in women’s healthcare is emerging as one of the most significant opportunities in global health, with the potential to unlock up to one trillion dollars annually while transforming outcomes for millions of women worldwide.
Recent global analysis highlights a striking imbalance. Although women represent nearly half of the global population and account for approximately seventy percent of the healthcare workforce, they spend a disproportionately greater portion of their lives in poor health. On average, women experience about twenty five percent more time in ill health compared to men, reflecting deep rooted gaps in research, clinical design, and healthcare delivery systems.
Beyond the human impact, the economic implications are substantial. Addressing these disparities could reduce the equivalent of seventy five million years of life lost annually due to poor health and early mortality. It could also generate productivity gains equivalent to one hundred thirty seven million full time jobs globally, positioning women’s health as both a healthcare priority and a critical driver of economic resilience.
At the core of the issue is a systemic lack of data and research focused on women’s health. Historically, healthcare systems and clinical research frameworks were not designed with women in mind. In many cases, women were excluded from clinical trials until relatively recently, resulting in gaps in medical understanding that continue to affect diagnosis, treatment, and outcomes today.
Kate Lancaster, Chief Executive Officer of the Royal College of Obstetricians and Gynaecologists, highlighted the structural nature of these challenges:
“My mission is simple: to improve the health of women and girls across the world by working in partnership with women and with institutions across the world to do so. Women are really struggling to access healthcare systems which have not been built around their needs. These structural disparities shape outcomes across a woman’s entire lifespan, and these disparities further deepen when you then apply race, disability and geography to that.”
A critical concern is the lack of investment in women specific health conditions. Despite the scale of the issue, less than one percent of healthcare research and innovation funding is directed toward conditions that primarily affect women outside of cancer. This imbalance has led to persistent gaps in diagnosis, treatment pathways, and preventive care models.
Experts emphasize that closing the women’s health gap requires a fundamental shift in how healthcare systems are designed and funded. It is not simply about increasing access, but about rethinking the entire lifecycle of care, from research and data collection to policy development and clinical practice.
Lancaster underscored the urgency of embedding women’s health into global healthcare strategies:
“Women’s health must be at the heart of local, national, and international strategies so that every level of society women can achieve better access to healthcare, and we can safeguard this reality for the women and girls of tomorrow. And within those strategies, a vital pillar must be focused on closing the women’s data gap and research gap.”
Global health frameworks already point to the scale of opportunity. International health organizations estimate that coordinated investment in women’s health and nutrition can deliver returns many times greater than the initial investment, provided that funding is supported by strong governance, reliable data systems, and cross sector collaboration.
However, turning this potential into measurable progress requires alignment across multiple dimensions. Policymakers, healthcare providers, researchers, and investors must work together to ensure that ambition is translated into real world impact. This includes building data driven systems, prioritizing gender specific research, and designing healthcare services that reflect the realities of women’s lives across different stages and social contexts.
The broader message is clear. Closing the women’s health gap is not only a moral and clinical imperative, but also an economic and strategic one. As healthcare systems evolve to meet future challenges, prioritizing women’s health will be essential to building more equitable, sustainable, and effective global health systems.
